Matrix Asset Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Matrix Asset Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-50,000	Closed	-$314K	–	81
2020 Q2	$314K	Hold	50,000	–	–	0.06%	63
2020 Q1	$92K	Hold	50,000	–	–	0.02%	68
2019 Q4	$169K	Sell	50,000 -10,000	-17%	-$23.8K	0.03%	74
2019 Q3	$128K	Hold	60,000	–	–	0.02%	72
2019 Q2	$160K	Hold	60,000	–	–	0.03%	65
2019 Q1	$285K	Hold	60,000	–	–	0.05%	63
2018 Q4	$144K	Hold	60,000	–	–	0.03%	65
2018 Q3	$264K	Hold	60,000	–	–	0.04%	60
2018 Q2	$432K	Buy	60,000 +10,000	+20%	+$68K	0.07%	54
2018 Q1	$258K	Sell	50,000 -22,000	-31%	-$157K	0.04%	61
2017 Q4	$274K	Hold	72,000	–	–	0.04%	60
2017 Q3	$122K	Hold	72,000	–	–	0.02%	63
2017 Q2	$144K	Buy	72,000 +50,000	+227%	+$97.6K	0.02%	64
2017 Q1	$87K	Hold	22,000	–	–	0.02%	63
2016 Q4	$108K	Sell	22,000 -1,128	-5%	-$6.78K	0.02%	71
2016 Q3	$179K	Hold	23,128	–	–	0.03%	73
2016 Q2	$130K	Hold	23,128	–	–	0.03%	69
2016 Q1	$124K	Hold	23,128	–	–	0.02%	69
2015 Q4	$201K	Hold	23,128	–	–	0.04%	73
2015 Q3	$194K	Hold	23,128	–	–	0.03%	64
2015 Q2	$408K	Hold	23,128	–	–	0.05%	60
2015 Q1	$267K	Hold	23,128	–	–	0.03%	68
2014 Q4	$233K	Hold	23,128	–	–	0.03%	70
2014 Q3	$105K	Hold	23,128	–	–	0.01%	72
2014 Q2	$156K	Hold	23,128	–	–	0.02%	70
2014 Q1	$297K	Hold	23,128	–	–	0.04%	63
2013 Q4	$187K	Buy	+23,128	New	+$204K	0.02%	68

Other funds holding SRNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Matrix Asset Advisors's SRNE Position: Q3 2020 in Review

Matrix Asset Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2020, closing a stake of 50,000 shares — an estimated $314K sold.

Matrix Asset Advisors first reported a position in SRNE in Q4 2013 and held it in 27 quarters. The position peaked at $432K in Q2 2018. 209 funds tracked by Wall St. Rank hold SRNE as of Q3 2020.

Matrix Asset Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
Matrix Asset Advisors sold 50,000 Sorrento Therapeutics, Inc. shares in Q3 2020, an estimated $314K.
Matrix Asset Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2013 and held it in 27 quarters.
Matrix Asset Advisors's Sorrento Therapeutics, Inc. position peaked at $432K in Q2 2018.
209 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2020.

Based on Matrix Asset Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.